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Background: THO (Suppressors of the transcriptional defects of hpr1 delta by overexpression) complex 5 (THOC5),
an mRNA export protein, is involved in the expression of only 1% of all genes. Using an interferon inducible
knockout mouse system, we have previously shown that THOC5 is an essential element in the maintenance of
hematopoietic stem cells and cytokine-mediated hematopoiesis in adult mice. Here we interrogate THOC5
function in cell differentiation beyond the hematopoietic system and study pathological changes caused by
THOC5 deficiency.
Results: To examine whether THOC5 plays a role in general differentiation processes, we generated tamoxifen
inducible THOC5 knockout mice. We show here that the depletion of THOC5 impaired not only hematopoietic
differentiation, but also differentiation and self renewal of the gut epithelium. Depletion of the THOC5 gene did
not cause pathological alterations in liver or kidney.
We further show that THOC5 is indispensable for processing of mRNAs induced by Wnt (wingless/integrated)
signaling which play key roles in epithelial cell differentiation/proliferation. A subset of Wnt target mRNAs,
SRY-box containing gene 9 (Sox9), and achaete-scute complex homolog 2 (Ascl2), but not Fibronectin 1 (Fn1),
were down-regulated in THOC5 knockout intestinal cells. The down-regulated Wnt target mRNAs were able to
bind to THOC5. Furthermore, pathological alterations in the gastrointestinal tract induced translocation of intestinal
bacteria and caused sepsis in mice. The bacteria translocation may cause Toll-like receptor activation. We identified
one of the Toll-like receptor inducible genes, prostaglandin-endoperoxidase synthase 2 (Ptgs2 or COX2) transcript
as THOC5 target mRNA.
Conclusion: THOC5 is indispensable for processing of only a subset of mRNAs, but plays a key role in processing
of mRNAs inducible by Wnt signals. Furthermore, THOC5 is dispensable for general mRNA export in terminally
differentiated organs, indicating that multiple mRNA export pathways exist. These data imply that THOC5 may be
a useful tool for studying intestinal stem cells, for modifying the differentiation processes and for cancer therapy.
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The THO complex, which is a sub-member of TREX
(transcription/export), was originally identified in Sac-
charomyces cerevisiae as a five protein complex (Tho2p,
Hpr1p, Mft1p, Thp2p, and Tex1) [1-6] that plays a role
in transcriptional elongation, nuclear RNA export and
genome stability. In higher eukaryotes such as Drosophila
melanogaster [7] or humans [8], three proteins, (THOC1/
hHpr1/p84, THOC2/hRlr1, and THOC3) and three add-
itional unique proteins were identified, namely THOC5/
Fms interacting protein (FMIP) [9], THOC6 and THOC7,
as members of the THO complex. However, it is still
unclear whether all members of THO complex play a role
as one functional unit.
We have previously shown that THOC5 is a substrate
for several tyrosine kinases such as macrophage-colony
stimulating factor (M-CSF, or CSF-1) receptor, Fms [9],
and various leukemogenic tyrosine kinases, such as Bcr-
Abl (breakpoint cluster region-Abl tyrosine kinase fusion
protein), translocation-ets-leukemia (TEL)-platelet deri-
ved growth factor (PDGF) receptor, or nucleophosmin
(NPM)-anaplastic lymphoma kinase (ALK) [10,11]. In
addition, we have recently shown that DNA damage
causes loss of the RNA binding potential of THOC5
[12], and protein kinase C phosphorylates and inhibits
nuclear import of THOC5 [13], suggesting that THOC5
is regulated by extracellular signalling. Furthermore, the
ectopic expression or the depletion of THOC5 in mouse
myeloid progenitor or mesenchymal progenitor cell lines
causes abnormal hematopoiesis or abnormal muscle dif-
ferentiation, respectively, suggesting that the expression
level of THOC5 is important for the normal differenti-
ation process [9,10,14,15]. We have previously identified
THOC5 dependent mRNAs in the fibroblast system
[16]. Surprisingly, only 71 genes were downregulated by
depletion of THOC5. However, over 40% of these genes
were involved in differentiation processes. Furthermore,
we recently examined THOC5 dependent mRNAs in
monocytes/macrophages. In this system also, only 99
genes were down-regulated upon depletion of THOC5
[17]. Along the same line, depletion of THOC5 does not
affect bulk poly (A) + RNA export [18] and it has been
recently shown that the knockdown of THOC5 in Hela
cells leads to down-regulation of 289 genes [19].
Using interferon inducible THOC5 knockout mice, we
have previously shown that the depletion of the THOC5
gene causes rapid apoptosis of hematopoietic cells, but
not of any other organs. After bone marrow transplant-
ation, mice survived for more than 3 months without
any symptoms, suggesting that THOC5 plays a key role
in maintaining hematopoietic cells. However, since inter-
feron is one of the important cytokines for hema-
topoiesis [20], the observed phenotype may be due to
the synergistic effects of interferon and knockdown ofTHOC5. Furthermore, depletion of the THOC5 gene
resulting from treatment with poly I:C is limited to
certain organs.
We therefore generated tamoxifen inducible THOC5
knockout mice. The treatment of mice with tamoxifen
caused deletion of THOC5 exons 4/5 from bone marrow,
colon, stomach, jejunum, liver, and kidney. We show here
that THOC5 not only plays a key role in hematopoiesis,
but also in another regenerative organ, the gastrointestinal
tract. On the other hand, depletion of THOC5 in termin-
ally differentiated organs such as liver or kidney did not
result in any pathological alterations, nor did it influence
mRNA export. Finally, we show that a subset of wingless/
integrated (Wnt) target mRNAs is THOC5 dependent.
These data suggest that mRNA export protein THOC5
controls the differentiation in a wide range of regenerative
organs.
Results and discussion
THOC5 exons 4/5 were deleted from bone marrow, colon,
liver, and kidney, but not from lung after tamoxifen
treatment
To extend previous work on THOC5 function to a
broader range of organs and cell types, we generated a
novel inducible THOC5 knockout mouse strain. We
used tamoxifen-induced cre-recombinase expression in
Rosa26-CreERT2 mice [21]. In Rosa26-CreERT2 mice, the
CreERT2 fusion gene is under the control of the ROSA26
promoter and hence ubiquitously expressed in all or-
gans. However, gene recombination is only induced by
injection of the synthetic ligand, tamoxifen that leads to
formation of an active cre-recombinase [21]. THOC5
(flox/flox) mice (Figure 1A) were mated to Rosa26-
CreERT2 mice, generating tamoxifen inducible THOC5
knockout mice. The deletion mutation of THOC5 was
induced by intraperitoneal (i.p.) injection with tamoxifen
twice at 2-day intervals. We injected 5-9-week old
Rosa26-CreERT2 (n = 12) and Rosa26-CreERT2:THOC5
(flox/flox) mice (n = 12) with tamoxifen. Two or four
days after the first tamoxifen injection, mice were sacri-
ficed and deletion of a functional THOC5 was analyzed
by PCR using exons 4/5 specific primers in genomic
DNAs from bone marrow (BM), colon, kidney, liver,
lung and spleen. As control, exon 20 specific PCR was
performed. In all control Rosa26-CreERT2 mice and
Rosa26-CreERT2:THOC5 (flox/flox) mice without tam-
oxifen treatment, an exon 4/5 specific product (313 bp)
and exon 20 specific product (191 bp) were detected
from all organs. THOC5 exons 4/5 were deleted from
bone marrow (BM), colon, kidney and liver of Rosa26-
CreERT2:THOC5 (flox/flox) mice within 2 days after tam-
oxifen treatment, but not from lung and spleen (Figure 1B).
To examine whether THOC5 exons 4/5 were only partially
deleted in lung and spleen, genomic DNAs from lung and
Figure 1 THOC5 exons 4/5 were deleted from BM, colon, kidney, and liver after tamoxifen treatment. (A) The genomic structure of the
exon 2 (E2) to exon 6 (E6) THOC5 locus is depicted. THOC5 deficient mice were generated as described previously [23]. The loxP sites are located
before E4 and after E5. Rosa26-CreERT2 (wild type (wt)) (n = 12) and Rosa26-CreERT2:THOC5 (flox/flox) (flox/flox) (n = 12) mice were injected with
tamoxifen i. p. 2 times at 3-day intervals and were sacrificed 0, 2, 4 and 6 days after the first tamoxifen injection (3 mice for each preparation).
Genomic DNA, protein and RNA were isolated from the same organs. (B) Genomic DNAs were supplied for the determination of deletion of
exons 4/5 by PCR. PCR product: wild type allele: 313 bp; THOC5 E4/E5 del allele: 0 bp. As control, E20 specific primers (product: 191 bp) were
supplied. (C) Protein was extracted from organs as indicated and subjected to THOC5 and actin specific immunoblot. Total protein amount was
standardized by actin specific immunoblot. We performed 3 independent experiments and we show one example of representative data. (D)
THOC5 and actin specific bands were quantified using the TINA 2.0 software (see Methods-Immunoblot Procedures). The signal intensity of
THOC5 was standardized by actin band of each sample (3 mice for each preparation). The reduced percent signal intensity from mice treated
with tamoxifen are shown. Mean values from three independent experiments are shown. The error bars represent standard deviation. (E) RNAs
were extracted from liver or spleen of same mice as described above, and supplied for THOC5 (wt: 643 bp or delta E4/E5:429 bp) and GAPDH
(123 bp) specific RT-PCR.
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primers. Corresponding bands gave 1110 bp (with exons 4/
5) and 355 bp sizes (lacking exons 4/5), respectively. A
PCR product lacking exons 4/5 (355 bp) was detected in
both organs within 2 days (data not shown), indicating that
THOC5 exons 4/5 were only partially deleted in lung
and spleen.
We next examined THOC5 at the protein level. The
deletion of exons 4/5 of THOC5 causes a frame shift ofproduct and the truncated protein is expected to be only
83 amino acids long and lacking the THOC1 binding
domain [22]. However, we did not detect the truncated
small THOC5 product in all organs. The level of THOC5
protein did not change in organs from Rosa26-CreERT2
control mice before or after tamoxifen treatment, how-
ever in Rosa26-CreERT2:THOC5 (flox/flox) bone marrow,
colon, stomach, jejunum, kidney and liver the level of
THOC5 was reduced to less than 20% within 6 days in all
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shown). The level of THOC5 product in spleen was re-
duced by only 40% (Figure 1C and D). We then examined
the THOC5 mRNAs in spleen. As control, we applied
mRNA obtained from liver in which the THOC5 product
was reduced to 10% of control liver within 4 days after
tamoxifen treatment (Figure 1E). As expected, from liver
only mRNA without exons 4/5 (429 bp) was detected after
tamoxifen treatment. In agreement with data obtained
from genomic DNA and protein (Figure 1B and C), both
mRNA with (643 bp) and without (429 bp) exons 4/5 were
detected in spleen 2 and 4 days after tamoxifen treatment,
suggesting that THOC5 is deleted in a particular po-
pulation of spleen cells. Notably, in interferon inducible
THOC5 knockout mice, THOC5 was depleted in bone
marrow or liver, but not in the gastrointestinal tract [23],
while in tamoxifen inducible knockout mice THOC5 was
also depleted in the gastrointestinal tract.
THOC5 inactivation results in rapid death
To study the effects of THOC5 deletion, tamoxifen was
injected twice at 2 days intervals (Figure 2, arrows) in 6-
week old Rosa26-CreERT2:THOC5 (flox/flox) (n = 18)
and Rosa26-CreERT2 (n = 10) control mice. All Rosa26-
CreERT2:THOC5 (flox/flox) mice died within 1 week, while
control mice did not show any symptoms (Figure 2). Con-
sidering the kinetics of THOC5 inactivation after tamoxi-
fen injection and our previous observations in interferon-
inducible THOC5 inactivation, we speculated that loss of
THOC5 in kidney, liver, bone marrow and/or gut might
combine to cause lethality.Figure 2 Deletion of THOC5 is lethal in adult mice. Rosa26-
CreERT2:THOC5(flox/flox) (n = 18) and control Rosa26-CreERT2 (n = 10)
mice were injected with tamoxifen. Injection was performed i. p.
2 times at 2-day intervals (arrows: tamoxifen injection).Depletion of the THOC5 gene causes loss of nucleated
bone marrow cells
We have previously shown that using an interferon
inducible knockout mouse system THOC5 is essential to
sustain hematopoiesis in adult mice. We therefore exam-
ined whether tamoxifen inducible THOC5 knockout mice
show a similar phenotype. Spleen and bone marrow were
isolated from 6- to 9-week old Rosa26-CreERT2:THOC5
(flox/flox) (n = 17) and Rosa26-CreERT2 control (n = 14)
mice on day 0 (no tamoxifen) to day 6 after tamoxifen
treatment. In agreement with data using interferon indu-
cible THOC5 knockout mice, nucleated bone marrow
cells dropped in numbers already 2 days after tamoxifen
treatment and after 6 days nucleated cells were very scarce
(Figure 3A). Bone marrow cells from control mice did
not show any alteration after tamoxifen treatment
(data not shown).
Loss of proliferative cells in THOC5 depleted spleen
We then examined the effect on the spleen. Spleen
weight that is normalized to total body weight of control
Rosa26-CreERT2 mice was not altered after tamoxifen
treatment, while spleen weight of Rosa26-CreERT2:
THOC5 (flox/flox) was decreased to approximately half
5 or 6 days after tamoxifen treatment (Figure 3B). It
should be noted that at this period, THOC5 depleted
mice also lost approximately 20% body-weight. We then
counted cell numbers per mg spleen tissue. Six days
after tamoxifen treatment white cell numbers were de-
creased to 60% in THOC5 depleted mice (Figure 3C).
To determine which cell type(s) were decreased in
spleen by deletion of THOC5, we next examined the
morphological alterations to the spleen.
Although no obvious differences in the morphology of
the splenic parenchyma were detected between THOC5
depleted and control spleens, there is a clear reduction
in the number of B cells visualized by paired box 5
(PAX5) specific staining (Figure 3D). In addition, there
is a clear reduction in the fraction of Ki67 positive
proliferating cells (Figure 3D). The Ki67 positive cells in
the control spleens are mainly in the area in which there
is a lack of B-cells, including germinal centers, in the
THOC5 depleted spleen. This suggests that THOC5
depleted spleens do not contain proliferating B-cells. On
the other hand, no obvious difference was observed in
CD3 positive cells before or after tamoxifen treatment
(Figure 3D).
Depletion of the THOC5 gene did not cause pathological
alterations in liver or kidney
We next examined other organs, kidney and liver. In
agreement with our previous data [23], we did not see
any pathological alterations, such as inflammation, or
any activated caspase 3 positive cells in kidney or liver
Figure 3 Depression of the THOC5 gene causes apoptosis of bone marrow cells and reduction of the B cell population in spleen.
Rosa26-CreERT2:THOC5 (flox/flox) (n = 17) and control Rosa26-CreERT2 (n = 14) mice were injected with or without tamoxifen. Injection was
performed i. p. 2 times at 2-day intervals. (A) Bone marrow cells were spun down onto glass slides and were then stained with May-Grünwald
and Haematoxylin (May-Grünwald). We show one example of representative data. Bars represent 10 μm. (B, C) Spleen weight was shown as
mg/20 g body weight (B), haematoxylin positive cells were counted from 1 mg spleen (C). Mean values from mice treated with tamoxifen:
Rosa26-CreERT2:THOC5 (flox/flox) (n = 10) and control Rosa26-CreERT2 (n = 8) or without tamoxifen Rosa26-CreERT2:THOC5 (flox/flox) (n = 7) and
control Rosa26-CreERT2 (n = 6) are shown. The error bars represent standard deviation. (D) Rosa26-CreERT2:THOC5 (flox/flox) mice were treated
with (+) or without (−) tamoxifen and six days after the first tamoxifen injection mouse spleens were fixed in formalin. Paraffin sections were
stained by Haematoxylin and eosin (HE) or were supplied for immunohistochemical staining using CD3, PAX5 and Ki67 specific antibodies.
Bars represent 800 μm (HE) or 40 μm (immunohistochemical staining).
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of key molecules and enzymes such as albumin or trans-
ferrin for the maintenance of life, we examined whether
albumin or transferrin mRNAs were exported into thecytoplasm in the THOC5 depleted liver. We isolated
cytoplasmic and nuclear RNAs from 20 μg of liver tissue
before and after THOC5 knockdown (Figure 4C,D), and
then analyzed albumin, transferrin and actin expression
Figure 4 Depletion of the THOC5 gene did not cause pathological alteration to liver or kidney. (A) Rosa26-CreERT2:THOC5 (flox/flox) mice
were treated with (+) or without (−) tamoxifen and six days after the first tamoxifen injection, kidney and liver were fixed in formalin. Paraffin
sections were supplied for immunohistochemical staining using cleaved caspase 3 antibody. Bars represent 100 μm. (B) Protein extracts from liver
obtained from the same mice as in (A) were supplied for THOC5, cleaved (cl.) caspase 3, caspase 3 and actin specific immunoblot. (C) Nuclear
(Nuc) or cytoplasmic (Cyt) RNA from 20 μg of liver tissues before or after the tamoxifen treatment were supplied for the THOC5 specific RT-PCR or
nuclear (Nuc) or cytoplasmic (Cyt) protein extracts from same tissues (200 μg of liver tissue) were supplied for GAPDH and Histone H3 specific
immunoblot (Blot). (D) Aliquots of the same RNAs in (C) were supplied for Albumin, Transferrin and beta actin specific semi-quantitative RT-PCR.
Cycles: Number of amplification cycles.
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tionation, protein extracts of both fractions obtained
from 200 μg liver tissues were supplied for Histone H3
(nuclear fraction), and GAPDH (cytoplasmic fraction)
specific immunoblot (Figure 4C). In this experiment
only spliced forms of mRNA can be detected since we
have chosen the primer pair for RT-PCR which is
located at two different exons (Table 1). As shown in
Figure 4D, upon depletion of THOC5 the export of al-
bumin as well as transferrin mRNAs were not altered.
In addition, we examined the level of serum albumin
before and after tamoxifen treatment. The level of serumalbumin was not altered by depletion of THOC5 for
7 days (data not shown). Interestingly, liver expresses
THOC5 at relatively high levels on the protein and mRNA
levels [9], however our data revealed that THOC5 is not
required for maintenance of central liver functions. This
may be due to the strong regenerative potency of hepato-
cytes. We are currently examining the role of THOC5 in
regenerating liver. Furthermore, no pathological alter-
ations were found in other organs such as brain, heart,
lung, or testicles and no clear inflammatory response was
detected in THOC5 depleted organs at any time (data
not shown).
Table 1 RT-PCR primer pair sequences for selected genes




Alb (exon2-exon3) NM_009654.3 CAAGAGTGAGATCGCCCATCG TTACTTCCTGCACTAATTTGGCA x
Ascl2(exon1-exon2) NM_008554.3 AAGCACACCTTGACTGGTACG AAGTGGACGTTTGCACCTTCA x
Birc5 (exon3-exon 4) NM_009689.2 AGCATAGAAAGCACTCCCCTG CCACTGTCTCCTTCTCTAAGATCC x
Fn1 (exon41-exon43) NM_001276408.1 TTCAAGTGTGATCCCCATGAAG CAGGTCTACGGCAGTTGTCA x
GAPDH (exon2-exon3) NM_008084.2 AGGTCGGTGTGAACGGATTTG TGTAGACCATGTAGTTGAGGTCA x
GusB (exon1-exon2) NM_010368.1 CCGACCTCTCGAACAACCG GCTTCCCGTTCATACCACACC x
Mmp2 (exon1-exon2) NM_008610.2 CAAGTTCCCCGGCGATGTC TTCTGGTCAAGGTCACCTGTC x
Ptgs2 (exon8-exon9) NM_011198.3 TTCAACACACTCTATCACTGGC AGAAGCGTTTGCGGTACTCAT x
Snai1 (exon2-exon3) NM_011427.2 CAAGGAGTACCTCAGCCTGG GGTCAGCAAAAGCACGGTT x
Sox9 (exon2-exon3) NM_011448.4 CGGAACAGACTCACATCTCTCC GCTTGCACGTCGGTTTTGG x
Sox9 (exon2-intron2) NC_000077.6 AGTCGGTGAAGAACGGACAAG GAATGCAAAGTCAGATACTTCTG x
Beta-actin (exon4-exon5) NM_007393.3 AACACCCCAGCCATGTACGTAG GTGTTGGCATAGAGGTCTTTACGG x
Beta-actin (exon4-Intron4) AC_000027.1 GCTGTGCTATGTTGCTCTAGACTT TTTAGATGGAGAAAGGACTAGGC x
THOC5 (exon1- exon7) NM_172438.3 TCTGCCTTTTCACCTGGAAG CTCGGTACTTTTCTGCCAGC x
Trf (exon1-exon2) NM_133977.2 ACACACACACCGAGAGGAT GGTATTCTCGTGCTCTGACAC x
Wnt11 (exon6-exon7) NM_009519.2 GGTGGTACACCGGCCTATG TCACTGCCGTTGGAAGTCTTG x
Alb (exon2-exon3): albumin (131nt); Ascl2 (exon1-exon2): Achaete scute complex homolog 2 (115nt); ; Birc5 (exon3-exon4): Baculoviral IAP repeat-containing
5 (311nt); Fn1 (exon41-exon43): fibronectin1 (154nt); GAPDH (exon2-exon3): glyceraldehyde-3 phosphate dehydrogenase (123nt); GusB (exon1-exon2): glu-
couronidase beta (169nt); Mmp2 (exon1-exon2): matrix metallopeptidase 2 (171nt); Ptgs2 (exon8-exon9): prostaglandin-endoperoxidase synthase 2 (271nt);
Snai1 (exon2-exon3): snail homolog 1 (179nt); Sox9 (exon2-exon3): SRY-box containing gene 9 (163nt); Sox9 (exon2-intron2) (235nt); beta-actin (exon4-
exon5): (509nt); beta-actin (exon4-intron4) (191nt); THOC5 (exon1-exon7): THO complex subunit 5 homolog (643nt); Trf (exon1-exon2): transferrin (125nt);
Wnt11 (exon6-exon7): wingless-related MMTV integration site 11 (183nt); (): product size.
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cells causes severe degeneration
We next examined the gastrointestinal tract. Gastro-
intestinal tissues were isolated from 6- to 9-week old
Rosa26-CreERT2 and Rosa26-CreERT2:THOC5 (flox/flox)
mice on day 0 (no tamoxifen) to day 6 after tamoxifen
treatment. Notably, 6 days after tamoxifen treatment the
length of small intestine from Rosa26-CreERT2:THOC5
(flox/flox) mice was reduced to half (from 32–33 cm to
17–18 cm), and the length of colon was slightly reduced
(by approximately 20%). Depletion of THOC5 caused
severe degenerative lesions in the small intestine
(Figure 5A). The epithelial villi (Figure 5A, arrows) were
disordered and shortened, and the crypts (area of the
intestinal stem cells) in THOC5 depleted mice show
severe dilatation and necrosis (Figure 5A, asterisk), and
sometimes sloughing of cells (crypt abscesses). It should
be noted that the changes are minimally associated with
influx of inflammatory cells. We then examined THOC5
expression in intestinal epithelial cells. THOC5 is ex-
pressed in the nucleus of most intestinal epithelial cells,
including the most prevalent enterocytes, in control
mice and in non-treated Rosa26-CreERT2:THOC5 (flox/
flox) mice, however 3 days after tamoxifen treatment,
THOC5 was drastically reduced in the intestinal epithe-
lial cells from Rosa26-CreERT2:THOC5 (flox/flox) mice
(Figure 5B). We next stained serial sections with Ki67and cleaved caspase 3 specific antibodies. Upon deple-
tion of THOC5, Ki67 positive cells were drastically re-
duced (Figure 5C), while cleaved caspase 3 positive cells
were detected in the crypt lesion 3 days after tamoxifen
treatment, and 5 days after tamoxifen treatment cleaved
caspase 3 positive cells were distributed throughout
whole villi (Figure 5D), suggesting that the structural
breakdown of stem cell niche, and/or bacterial infection
causes apoptosis of more differentiated epithelial cells.
THOC5 expression was drastically reduced not only in
small intestine, but also in caecum and colon from
THOC5 depleted mice 5 days after tamoxifen treatment
(Figure 5E). Furthermore, depletion of THOC5 caused
severe degenerative lesions in the small intestine, and
some parts of caecum, and to a lesser extent in the large
intestine (Figure 5E). Severe pathological alterations in
small intestinal epithelial cells may be due to the rapid
turnover of epithelial cells, however we observed patho-
logical alterations clearly in caecum and colon, where
the rate of turnover and proliferation is also quite high,
suggesting that THOC5 is required generally for rapidly
proliferating cells in the gut. This is quite different from
THOC1 (another member of the THO complex) knock-
out phenotype which showed that pathological alteration
was observed only in stem cells from the small intestine
[24]. It is not clear whether the function of THOC1 and/
or the efficiency of the tamoxifen inducible system are
Figure 5 Depletion of the THOC5 gene causes severe pathological alteration in the gastrointestinal tract. Rosa26-CreERT2 and Rosa26-
CreERT2:THOC5 (flox/flox) mice were treated with (+) or without (−) tamoxifen and jejunum (A-E), caecum (E), and colon (E) were fixed in formalin.
Paraffin sections were stained by hematoxylin and eosin (HE) (A) or were supplied for immunohistochemical staining using THOC5 (B, E), Ki67 (C), and
cleaved caspase 3 (Cl. Caspase 3) (D) specific antibodies as indicated. Bars represent 400 μm (HE) or 20 μm (immunohistochemical staining).
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pathological alterations in tamoxifen treated control mice.
The damage of epithelial cells caused translocation of bac-
teria into the underlying blood vessels (data not shown),
which may cause Toll-like receptor activation [25].
Depletion of the THOC5 gene causes bacterial infection
that originates from the gastrointestinal tract
We next isolated blood from heart and incubated it on
blood agar plates. No bacterial colonies grew until 2 days
after tamoxifen treatment, however colonies (39 and 41
colonies/100 μl blood) were detected in blood from heart
in 2 out of 3 mice 4 days after tamoxifen treatment. Fiveto seven days after tamoxifen treatment, more than 400
bacterial colonies were isolated from 100 μl blood from
heart of all THOC5 depleted mice (Table 2). Bacterial
colonies were not observed from control mice at any time
point. To confirm that the bacteria which were obtained
from heart blood originated from the intestines, we next
identified bacterial strains in blood from the heart by
DNA sequencing using a SOLiD 5500XL system. Ninety-
seven% of isolated bacteria were identified as Gammapro-
teobacteria that include Escherichia coli that in our mouse
colony represents a minor but readily detectable constitu-
ent of the gut microbiota (Table 3). This indicates that
bacteria detectable in blood indeed originated from the
Table 2 Depletion of THOC5 gene leads to sepsis
Rosa26-CreERT2:
THOC5 (flox/flox)
Number of bacteria colonies
(100 μl of blood from heart)
Day 0 Day 2 Day 4 Days 5–7
1 0 0 41 >500
2 0 0 39 420
3 0 0 0 >500
Rosa26-CreERT2:THOC5 (flox/flox) (n = 12) mice were injected with tamoxifen.
Blood samples were taken from the heart on 0, 2, 4, or 5-7 days after the first
injection. Blood samples of 100 μl were plated onto blood agar and colony
numbers of bacteria from each mouse are shown.
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of sepsis. Since mice also exhibit several defects in im-
mune system (Figure 3), the immune defects may also
contribute to the onset of sepsis.
THOC5 is indispensable for processing of inducible
mRNAs by Wnt or Toll-like receptor signaling
Wnt/beta-catenin signaling is a major regulator of homeo-
static self-renewal within the intestinal crypt [26,27].
Evidences have accumulated that the THO complex plays
an important role in processing of a subset of genes in-
duced by growth factors/cytokines, serum or heat-shock.
Thereby, the THO complex is recruited to its target genes
and then binds to the target mRNAs [12,16,19,28,29]. We
next examined whether Wnt target mRNAs are processed
in a THOC5 dependent manner. It must be noted that we
have previously identified THOC5 target mRNAs using
the mouse embryonic fibroblast system [16]. One of these
target mRNAs is SRY-box containing gene 9 (Sox9)
mRNA which is one of the known Wnt targets [30-35].
We performed Sox9 specific in situ hybridization in
THOC5 depleted intestines. Sox9 transcripts were de-
tected in the intestinal crypt in control intestines, however
upon depletion of THOC5, the Sox9 transcript was
reduced (Figure 6A). We further examined other Wnt
target mRNAs, achaete-scute complex homolog 2 (Ascl2)
[31], and fibronectin 1 (Fn1) [35]. In control intestines
Ascl2 is expressed in the intestinal crypt [31], while Fn1Table 3 Depletion of THOC5 gene causes bacterial








Bacteria derived from mice treated with tamoxifen for 6 days were grown
overnight on blood agar and the bacterial DNA was isolated. Bacterial strains
were identified by sequencing as detailed in Methods. Percent of bacterial
strains from all bacteria are shown.was detected also in villi (Figure 6A). Upon depletion of
THOC5, the Ascl2 but not Fn1 transcripts were reduced
(Figure 6A). Beta-actin transcripts were detected at un-
altered levels in control and THOC5 depleted small intes-
tine. These data suggest that some of Wnt target mRNAs
may be THOC5 dependent. However, THOC5 depletion
partially causes the loss of cellularity in the small intestine,
and we therefore cannot rule out that depletion of Wnt
target mRNAs is simply due to the pathological alteration
of the small intestine or due to a reduction in the numbers
of cells expressing these mRNAs. We then further con-
firmed that Wnt target mRNAs are indeed THO complex
dependent by isolating THOC5-mRNAs complex [12,16].
For this experiment, endogenous THOC5 was immuno-
precipitated by THOC5 specific monoclonal antibody
from the nuclear fraction from mouse embryonic fi-
broblasts, or mouse hepatocellular carcinoma cell line,
HEPA1-6. As control, the same fraction was precipitated
by normal mouse IgG. Notably, THOC1 was detected in
the THOC5 specific immunoprecipitates, but not in the
control IgG precipitates (Figure 6B). THOC5-mRNA
complex was examined by RT-PCR using specific primers
for detection of 7 Wnt target mRNAs [30-35], namely, the
Sox9, Ascl2, snail family zinc finger 1 (Snai1), wingless-
related MMTV integration site 11 (Wnt11), Baculoviral
IAP repeat-containing 5 (Birc5 or Survivin), matrix metal-
lopeptidase 2 (MMP2) and Fn1, and as controls, GusB
and beta-actin transcripts were examined. As shown in
Figure 6B, Wnt target mRNA, Sox9, Ascl2, Snai1, Wnt11,
and Survivin, but not MMP2 or Fn1, were detected in the
THOC5-mRNAs complex, indicating that a subset of
Wnt target mRNAs are indeed THOC5 dependent. Along
the same line, we recently found that cytokine induced
immediate-early genes, v-ets erythroblastosis virus E26
oncogene homolog 1 (Ets1) or Ets2, but not early growth
response 1 (Egr1), were THOC5 dependent, indicating
that not all induced genes were THOC5 dependent [17].
We then examined one of Toll-like receptor target
mRNAs, prostaglandin-endoperoxide synthase 2 (Ptgs2 or
Cox2). Ptgs2 mRNA was also isolated in the THOC5-
mRNA complex (Figure 6B), indicating that Toll-like re-
ceptor signalling is also impaired by depletion of THOC5.
We next examined whether THOC5 plays a role in pro-
cessing of Wnt target mRNAs, Sox9 or Ascl2. We isolated
nuclear and cytoplasmic RNA from THOC5 depleted
mouse embryonic fibroblasts (MEF) or bone marrow
derived macrophages derived from Rosa26-CreERT2:
THOC5 (flox/flox) mice. Beta actin mRNA was used as
an internal control for equal amounts of cDNA used for
each sample (Figure 6C, actin). As control for fraction-
ation, aliquots of protein extracts from each sample were
supplied for Histone H3 (nuclear fraction), and GAPDH
(cytoplasmic fraction) specific immunoblot (Blot). Spliced
Sox9 and Ascl2 mRNAs were exported in the presence of
Figure 6 Wnt signaling downstream genes are THOC5 target mRNAs. (A) In situ hybridization: Frozen sections of small intestine from
Rosa26-CreERT2:THOC5 (flox/flox) or Rosa26-CreERT2 mice 3 days after tamoxifen treatment were hybridized with Sox9, Ascl2, Fn1 or beta-actin
specific probes and counterstained with DAPI. Bars represent 40 μm. (B) Endogenous THOC5 was immunoprecipitated from the nuclear fraction
of mouse embryonic fibroblasts or mouse hepatocellular carcinoma cell line HEPA1-6 using THOC5 specific monoclonal antibody (anti THOC5
IgG) and control mouse IgG (control IgG). THOC5-mRNA complex was analyzed by THOC5 or THOC1 specific immunoblot or bound RNAs were
examined by Sox9, Ascl2, Snai1, Birc5, Wnt11, MMP2, Fn1, Ptgs2, GusB, and beta-actin specific RT-PCR. (C) MEF or Bone marrow derived
macrophages were isolated from Rosa26-CreERT2:THOC5 (flox/flox) mice. Cells were incubated with (+) and without (−) tamoxifen (10 μM) for
three days, and nuclear (Nuc) and cytoplasmic (Cyt) RNAs were then isolated and applied to spliced Ascl2, Sox9, THOC5 or actin specific
semi-quantitative RT-PCR using primers as described in Table 1. cDNA from all samples were standardized by adjusting equal levels of actin
mRNA in both fractions. Protein extracts were supplied for GAPDH and Histone H3 specific immunoblot (Blot). We performed 3 independent
experiments and we show one example of representative data. (D) Aliquots of nuclear RNAs in (C) were supplied for spliced (E2-E3: Exon2-Exon3)
or unspliced(E2-I2: Exon2-Intron2) Sox9, or spliced (E4-E5: Exon4-Exon5) and unspliced (E4-I5: Exon4-Intron4) beta actin specific RT-PCR
(primers: Table 1). RT: reverse transcriptase reaction.
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http://www.biomedcentral.com/1471-2121/14/51THOC5, however, depletion of THOC5 drastically redu-
ced the export (Figure 6C). To determine the effect of
THOC5 in the target mRNA processing, we next exam-
ined the spliced and unspliced forms of Sox9 mRNA in
the nuclear fraction before and after deletion of THOC5.
The unspliced form of Sox9 mRNA also accumulated in
the nucleus upon depletion of THOC5 (Figure 6D), indi-
cating that THOC5 contributes not only to the mRNA
export, but also to the efficient processing of target mRNA
or the degradation of unspliced mRNAs.
Presently, it is not clear how the THO complex selects
its target mRNAs. Recently, Katahira et al. [19] proposedthat THOC5 controls an alternative polyadenylation site
choice by recruiting cleavage and polyadenylation specific
factor 6, (CPSF6, or CFIm68) on target genes. However,
70-75% of human mRNAs contain a potential alternative
polyadenylation site [36]. Moreover, Snai1 (THOC5 de-
pendent gene) does not contain this site. Alternatively, it
has been previously shown in the yeast system that yeast
homolog of THOC1, Hpr1 is preferentially required for
transcription of either long or GC rich DNA sequences
[2]. Interestingly, the coding region (not in the 3′-UTR) of
Sox9, Ascl2, Snai1, and Wnt11 (THOC5 dependent genes)
contain GC to a great degree (61-67%), while THOC5
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http://www.biomedcentral.com/1471-2121/14/51independent genes contain 54-55% GC. However, the tar-
get selectivity of THOC5 remains to be studied.
It has been previously shown that depletion of the
Wnt target gene, Ascl2 results in a similar phenotype
with pathological alterations of small intestinal epithelial
cells [37] to the phenotype observed in THOC5 depleted
epithelial cells, however THOC5 depleted mice showed
more severe alterations of phenotype than Ascl2 −/−
mice. This may be due to the fact that THOC5 knockout
causes depletion of the pool of Wnt target mRNAs.
These data imply that some population of genes indu-
cible by growth factors/cytokines, Wnt signaling, and
probably also Toll-like receptor signaling are THOC5
dependent, thus THOC5 plays a crucial role in prolifera-
tion/differentiation processes in regenerative organs. Fur-
thermore, these data also provide evidence that THOC5
may be a useful tool for modification of the differentiation
processes, and for cancer therapy.Conclusion
THOC5 is indispensable for processing of only a sub-
set of mRNAs, but plays a key role in processing of
mRNAs inducible by Wnt signals. Furthermore,
THOC5 is dispensable for general mRNA export in termin-
ally differentiated organs, indicating that multiple mRNA
export pathways exist. These data imply that THOC5
may be a useful tool for studying intestinal stem cells,
for modifying the differentiation processes and for
cancer therapy.Methods
Genotyping for Rosa26-CreERT2:THOC5 (flox/flox) and
Rosa26-CreERT2 mice
Generation of THOC5 (flox/flox) mice has been de-
scribed previously [23]. Genotyping was performed from
tail-derived sample DNA extracted with DirectPCR-Tail
Lysis Reagent (Peqlab, Erlangen, Germany) by PCR using
THOC5 primers flanking the floxed region with 5′-
CCCTCGGCCCCTTTTGAG-3′ and 5′-CAGCACTGG
AGCGGGAGATGT-3′ [23]. After crossing with Rosa26
ERT2-Cre deleter mice (A kind gift from Anton Berns,
Netherlands Cancer Institute), mice were genotyped by
PCR using primers Cre1 5′-CCGGGCTGCCACGAC
CAA-3′ and Cre2 5′-GGCGCGGCAACACCATTTT-3′
for Cre gene and primers for floxed THOC5 gene. For the
determination of exons 4/5 deletion, exon 4/5 specific PCR
primers: 5′-CTGTGTGCACTTCATGACTCTAAAGA-3′
and 5′-GAACTCCAGACATTTGGTGATCTCCT-3′, in-
trons 3/5 specific PCR primers: 5′-TGCTGGCATTG
AACTGTG-3′ and 5′-CAGCACTGGAGCGGGAGAT
GT-3′ and exon 20 specific PCR primers: 5′-GCTATG
GAGAGTGAAGTCAACGTGT-3′ and 5′-CTAAAAAG
CCGCAGGCACATCTT −3′ were used.RT-PCR analysis
RNA was isolated from mouse tissue with the High
Pure RNA Isolation kit (Roche Diagnosis, Mannheim,
Germany) according to the manufacturer’s instructions.
To isolate cytoplasmic RNAs from liver we used NE-
PER nuclear and cytoplasmic extraction reagents (Pierce,
Thermo Scientific, Germany). Reverse transcription was
carried out using oligo dT primers and the Omniscript
reverse transcriptase kit (Qiagen, Hilden, Germany)
following the instructions provided. Primer pairs for each
PCR are shown in Table 1. PCRs were set up according to
the following profile: an initial denaturation step of 94°C
for 3 minutes, 35 cycles of 94°C for 30 seconds, 60°C for
30 seconds, and 72°C for 30 seconds followed by a final
extension step at 72°C for 10 minutes. Separation of the
DNA fragments was carried out on 2% (w/v) agarose gels,
stained with ethidium bromide (2 μg/ml) and photo-
graphed under UV light.
Tamoxifen injection
Tamoxifen (Sigma, München, Germany) was injected i.p.
(1 mg/20 g body weight) into 5–9 week-old mice, two
times at 2-day intervals. All animal experiments were car-
ried out according to institutional guidelines approved by
the Niedersächsisches Landesamt für Verbraucherschutz
und Lebensmittelsicherheit. This study was approved
under permit number: 33.14-42502-04-12/0762.
Hematopoiesis assays
Cytospin preparations were generated from bone marrow
cells and contrast was enhanced by May-Grünwald and
hematoxylin staining.
Immunohistochemistry and immunofluorescence
Immunohistochemical studies were performed as detailed
previously [38]. Monoclonal Rat anti mouse Ki67 and
polyclonal rabbit anti CD3 antibodies were purchased
from Dakocytomation (Gloslrup, Denmark) and mouse
monoclonal antibody against Pax5 was from BD Biosci-
ences (Heidelberg, Germany). The monoclonal antibody
against THOC5 was described previously [15].
Immunoblot procedures
Details of immunoblotting have been described previ-
ously [39]. Mouse organs were extracted with lysis buffer
containing 10 mM Tris HCl pH 7.6, 50 mM NaF, 1 mM
PMSF, 10 mM EDTA, 1%(w/v) Triton-X 100, 8 M
Urea and protease inhibitor cocktail (Sigma, München,
Germany). Monoclonal antibody against GAPDH, and
polyclonal antibody against actin, were purchased from
Santa Cruz Biotechnology, Inc. (Santa Cruz, CA), poly-
clonal antibodies against cleaved caspase 3, caspase 3, and
Histone H3, were from Cell Signaling (Cell Signaling
Technology, Beverly, MA), a monoclonal antibody against
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responding proteins were visualized by incubation with
peroxidase conjugated anti-mouse or anti-rabbit immuno-
globulin followed by incubation with SuperSignal West
FemtoMaximum Sensitivity Substrate (Pierce Protein
Biology Products, Rockford, IL, USA). Results were doc-
umented on a LAS4000 imaging system (GE Healthcare
Bio-Sciences, Uppsala, Sweden). Signal intensity of chemi-
luminescence was quantified using TINA 2.0 software
(Raytest Isotopenmessgeraete GmbH, Straubenhardt,
Germany).
Bacteria DNA- sequencing
One-hundred microliter samples of blood taken from the
heart were plated on blood agar and incubated overnight
at 37°C. Bacteria were isolated from the plate and genomic
DNA from the bacteria was prepared. Sequencing was
performed on a SOLiD 5500XL –System (Life technolo-
gies). To generate a bead-coupled fragment library for
high throughput sequencing, the bacterial DNA was frag-
mented and processed using kits and standard protocols
of Life technologies (Fragment Library Preparation: 5500
Series SOLiD™ Systems User Guide (Part no. 4460960),
5500 SOLiD™ Fragment Library Core Kit (Part no.
4464412) and EZ Bead™ E20 System Consumables (Part
no. 4453094)). Subsequent analysis was performed with
the program Genometa [40].
THOC5-mRNA complex isolation
After three times washing, mouse embryonic fibroblasts
or HEPA1-6 cells were lysed with lysis buffer (10 mM
Tris, 150 mM NaCl, 1 mM PMSF, 0.5% NP40, protease
inhibitor cocktail, (Sigma-Aldrich, München, Germany)
and RNase inhibitor), and were then frozen and thawed
three times. After centrifugation, supernatants were
incubated with mouse monoclonal THOC5 antibody or
mouse control IgG with protein G sepharose, and immu-
noprecipitates were then washed three times. All steps
were carried out at 4°C. Bound RNAs were employed for
RT-PCR analysis [12].
in situ hybridization
Small intestines were removed from control Rosa26-
CreERT2 mice and Rosa26-CreERT2:THOC5 (flox/flox)
mice 3 days after tamoxifen injection and flushed with 3%
FCS/PBS to remove faecal content. The intestines were
cut open longitudinally, rolled into compact circle and
frozen in Optimal cutting temperature (OCT) blocks in
dry ice. Sections of 5–7 μm thickness were prepared and
processed for hybridization as described below. Sections
were fixed in 4% paraformaldehyde, dehydrated, digested
with proteinase K solution (Thermo Scientific), acetylated
by 0.25% acetic anhydride, washed in 2X saline-sodium cit-
rate (SSC) buffer, dehydrated and hybridized with in vitrotranscribed anti-sense Sox9 (NM_011448.4: Probe: 557–
1137 (nucleotide numbers)), Ascl2 (NM_00855 4.3 Probe:
1125–1538 (nucleotide numbers)), Fn1 (NM_001276408.1
Probe: 5021–5370 (nucleotide numbers) and beta actin
(NM_007393.3: Probe 448–956 (nucleotide numbers))
RNAs overnight or 6 hours in moist chamber at 42°C. The
hybridization buffer contains 50% formamide, 0.6 M NaCl,
10 mM Tris.HCl, pH 7.5, 2 mM EDTA, 1× Denhardt’s
solution, 1 mg/ml yeast tRNA,10% dextran sulphate, and
10 mM DTT. Sections were then washed at 50°C in pre-
warmed RNA wash solution I (2X SSC, 50% formamide,
0.1% 2-mercaptoethanol), treated with 20 μg/ml Ribo-
nuclease A and further washed with RNA wash solu-
tion I and II (0.1X SSC, 1% 2-mercaptoethanol). After
dehydration and drying, sections were incubated for
4 hours at RT in anti-Digoxigenin-Rhodamine (1:100,
Roche Diagnostics GmbH). After washing several
times in Tris-buffered saline, sections were counterstained
with 4′,6-diamidino-2-phenylindole (DAPI). For image
analysis, sections were permanently mounted in Mowiol
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